Paul Howard, Ph.D., is a Manhattan Institute senior fellow and director of the Manhattan Institute's Center for Medical Progress. He is the managing editor of Medical Progress Today, a blog providing a forum for economists, scientists, and policy experts to explore the scientific, regulatory, and market frameworks that will best support twenty-first century medical innovation.
He has written on a wide variety of medical policy issues, including FDA reform, biopharmaceutical innovation, consumer-driven health care, Medicare and Medicaid policy, and health care reform. He is often quoted on health care issues and his columns and essays have appeared in national publications, including Bloomberg View, The Wall Street Journal, National Affairs, USA Today, Real Clear Politics, New York Post, Investor's Business Daily, Health Affairs, and FoxNews.com.
He is also a member of the Manhattan Institute's Project FDA, a committee of physician-scientists, economists, medical ethicists, and policy experts. Their purpose is to show how twenty-first-century technologies can help better inform FDA regulations and accelerate the drug-development and drug-approval process while maintaining drug safety.
In 2012, Howard served on the Health Care Policy Advisory Group for the presidential campaign of former Massachusetts governor Mitt Romney. He has also testified twice before Congress.
Howard joined the Manhattan Institute in 2000, working as deputy director of the Center for Legal Policy where he edited research papers, managed legal policy analyses, and organized conferences.
Howard received his Ph.D. in political science from Fordham University in 2003, and is a graduate of the College of the Holy Cross in Worcester, Massachusetts.